175 related articles for article (PubMed ID: 36067611)
1. A comparative assessment of myelin-sensitive measures in multiple sclerosis patients and healthy subjects.
Rahmanzadeh R; Weigel M; Lu PJ; Melie-Garcia L; Nguyen TD; Cagol A; La Rosa F; Barakovic M; Lutti A; Wang Y; Bach Cuadra M; Radue EW; Gaetano L; Kappos L; Kuhle J; Magon S; Granziera C
Neuroimage Clin; 2022; 36():103177. PubMed ID: 36067611
[TBL] [Abstract][Full Text] [Related]
2. Postmortem quantitative MRI disentangles histological lesion types in multiple sclerosis.
Galbusera R; Bahn E; Weigel M; Schaedelin S; Franz J; Lu PJ; Barakovic M; Melie-Garcia L; Dechent P; Lutti A; Sati P; Reich DS; Nair G; Brück W; Kappos L; Stadelmann C; Granziera C
Brain Pathol; 2023 Nov; 33(6):e13136. PubMed ID: 36480267
[TBL] [Abstract][Full Text] [Related]
3. Personalized maps of T1 relaxometry abnormalities provide correlates of disability in multiple sclerosis patients.
Chen X; Schädelin S; Lu PJ; Ocampo-Pineda M; Weigel M; Barakovic M; Ruberte E; Cagol A; Marechal B; Kober T; Kuhle J; Kappos L; Melie-Garcia L; Granziera C
Neuroimage Clin; 2023; 37():103349. PubMed ID: 36801600
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal microstructural MRI markers of demyelination and neurodegeneration in early relapsing-remitting multiple sclerosis: Magnetisation transfer, water diffusion and g-ratio.
York EN; Meijboom R; Thrippleton MJ; Bastin ME; Kampaite A; White N; Chandran S; Waldman AD;
Neuroimage Clin; 2022; 36():103228. PubMed ID: 36265199
[TBL] [Abstract][Full Text] [Related]
5. Comparing myelin-sensitive magnetic resonance imaging measures and resulting g-ratios in healthy and multiple sclerosis brains.
Berg RC; Menegaux A; Amthor T; Gilbert G; Mora M; Schlaeger S; Pongratz V; Lauerer M; Sorg C; Doneva M; Vavasour I; Mühlau M; Preibisch C
Neuroimage; 2022 Dec; 264():119750. PubMed ID: 36379421
[TBL] [Abstract][Full Text] [Related]
6. Myelin heterogeneity for assessing normal appearing white matter myelin damage in multiple sclerosis.
Johnson P; Vavasour IM; Stojkova BJ; Abel S; Lee LE; Laule C; Tam R; Li DKB; Ackermans N; Schabas AJ; Chan J; Cross H; Sayao AL; Devonshire V; Carruthers R; Traboulsee A; Kolind SH
J Neuroimaging; 2023 Mar; 33(2):227-234. PubMed ID: 36443960
[TBL] [Abstract][Full Text] [Related]
7. Normal appearing and diffusely abnormal white matter in patients with multiple sclerosis assessed with quantitative MR.
West J; Aalto A; Tisell A; Leinhard OD; Landtblom AM; Smedby Ö; Lundberg P
PLoS One; 2014; 9(4):e95161. PubMed ID: 24747946
[TBL] [Abstract][Full Text] [Related]
8. Using quantitative magnetic resonance imaging to track cerebral alterations in multiple sclerosis brain: A longitudinal study.
Vandeleene N; Guillemin C; Dauby S; Requier F; Charonitis M; Chylinski D; Balteau E; Maquet P; Lommers E; Phillips C
Brain Behav; 2023 May; 13(5):e2923. PubMed ID: 37078406
[TBL] [Abstract][Full Text] [Related]
9. Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosis.
Yik JT; Becquart P; Gill J; Petkau J; Traboulsee A; Carruthers R; Kolind SH; Devonshire V; Sayao AL; Schabas A; Tam R; Moore GRW; Li DKB; Stukas S; Wellington C; Quandt JA; Vavasour IM; Laule C
Mult Scler Relat Disord; 2022 Jan; 57():103366. PubMed ID: 35158472
[TBL] [Abstract][Full Text] [Related]
10. NODDI, diffusion tensor microstructural abnormalities and atrophy of brain white matter and gray matter contribute to cognitive impairment in multiple sclerosis.
Preziosa P; Pagani E; Meani A; Marchesi O; Conti L; Falini A; Rocca MA; Filippi M
J Neurol; 2023 Feb; 270(2):810-823. PubMed ID: 36201016
[TBL] [Abstract][Full Text] [Related]
11. A pilot study comparing myelin measurements from myelin water imaging and
Vavasour IM; Vafai N; Beauchemin P; Kanjilal C; Badalan A; Shahinfard E; Laule C; Li DK; Traboulsee A; Sossi V; Kolind SH; Carruthers RL
Mult Scler Relat Disord; 2022 Dec; 68():104238. PubMed ID: 36274287
[TBL] [Abstract][Full Text] [Related]
12. Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis.
Pietroboni AM; Colombi A; Contarino VE; Russo FML; Conte G; Morabito A; Siggillino S; Carandini T; Fenoglio C; Arighi A; De Riz MA; Arcaro M; Sacchi L; Fumagalli GG; Bianchi AM; Triulzi F; Scarpini E; Galimberti D
Eur Radiol; 2023 Aug; 33(8):5368-5377. PubMed ID: 36562783
[TBL] [Abstract][Full Text] [Related]
13. Myelin water imaging in relapsing multiple sclerosis treated with ocrelizumab and interferon beta-1a.
Kolind S; Abel S; Taylor C; Tam R; Laule C; Li DKB; Garren H; Gaetano L; Bernasconi C; Clayton D; Vavasour I; Traboulsee A
Neuroimage Clin; 2022; 35():103109. PubMed ID: 35878575
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the heterogeneous pathological substrates of relapse-onset multiple sclerosis: a multiparametric voxel-wise 3 T MRI study.
Margoni M; Pagani E; Preziosa P; Gueye M; Azzimonti M; Rocca MA; Filippi M
J Neurol; 2023 Aug; 270(8):3839-3850. PubMed ID: 37093395
[TBL] [Abstract][Full Text] [Related]
15. Exploring in vivo lesion myelination dynamics: Longitudinal Myelin Water Imaging in early Multiple Sclerosis.
Kitzler HH; Wahl H; Kuntke P; Deoni SCL; Ziemssen T; Linn J; Köhler C
Neuroimage Clin; 2022; 36():103192. PubMed ID: 36162236
[TBL] [Abstract][Full Text] [Related]
16. A New Advanced MRI Biomarker for Remyelinated Lesions in Multiple Sclerosis.
Rahmanzadeh R; Galbusera R; Lu PJ; Bahn E; Weigel M; Barakovic M; Franz J; Nguyen TD; Spincemaille P; Schiavi S; Daducci A; La Rosa F; Absinta M; Sati P; Bach Cuadra M; Radue EW; Leppert D; Kuhle J; Kappos L; Brück W; Reich DS; Stadelmann C; Wang Y; Granziera C
Ann Neurol; 2022 Sep; 92(3):486-502. PubMed ID: 35713309
[TBL] [Abstract][Full Text] [Related]
17. Evaluating brain damage in multiple sclerosis with simultaneous multi-angular-relaxometry of tissue.
Xiang B; Wen J; Schmidt RE; Sukstanskii AL; Mamah D; Yablonskiy DA; Cross AH
Ann Clin Transl Neurol; 2022 Oct; 9(10):1514-1527. PubMed ID: 36178006
[TBL] [Abstract][Full Text] [Related]
18. Quantitative magnetic resonance imaging biomarkers for cortical pathology in multiple sclerosis at 7 T.
Straub S; El-Sanosy E; Emmerich J; Sandig FL; Ladd ME; Schlemmer HP
NMR Biomed; 2023 Mar; 36(3):e4847. PubMed ID: 36259249
[TBL] [Abstract][Full Text] [Related]
19. Quantitative susceptibility mapping versus phase imaging to identify multiple sclerosis iron rim lesions with demyelination.
Huang W; Sweeney EM; Kaunzner UW; Wang Y; Gauthier SA; Nguyen TD
J Neuroimaging; 2022 Jul; 32(4):667-675. PubMed ID: 35262241
[TBL] [Abstract][Full Text] [Related]
20. Quantitative 7T sodium magnetic resonance imaging of the human brain using a 32-channel phased-array head coil: Application to patients with secondary progressive multiple sclerosis.
Wilferth T; Mennecke A; Gast LV; Lachner S; Müller M; Rothhammer V; Huhn K; Uder M; Doerfler A; Nagel AM; Schmidt M
NMR Biomed; 2022 Dec; 35(12):e4806. PubMed ID: 35892310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
